MiRNAs in cancer: The case of liver tumors;Micro-ARN (miARN) et cancer: Le cas des tumeurs hépatocellulaires

Medecine/Sciences

Volumn 25, Issue 5, 2009, Pages 467-472

  Ladeiro, Yannick ^a   Zucman Rossi, Jessica ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; THYMIDYLATE SYNTHASE; UNTRANSLATED RNA;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 13Q; DIAGNOSTIC PROCEDURE; GENE CONTROL; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MICROARRAY ANALYSIS; NORTHERN BLOTTING; ONCOGENE; PATHOPHYSIOLOGY; PRECANCER; PROGNOSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 66849121875     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2009255467     Document Type: Review

References (37)

1. Cullen BR. Transcription and processing of human microRNA precursors. Mol cell 2004 ; 16 : 861-865
2. Finoux AL, Chartrand P. Oncogenic and tumour suppressor microRNAs. Med Sci (Paris) 2008 ; 24 : 1049-1054
3. Calin GA, Croce CM. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Sem in Oncol 2006 ; 33 : 167-173
4. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005 ; 102 : 13944-13949 (Pubitemid 41377683)
5. Linsley PS, Schelter J, Burchard J, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007 ; 27 : 2240-2252 (Pubitemid 46418479)
6. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005 ; 435 : 834-838
7. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs : key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008 ; 27 : 5959-5974
8. Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004 ; 101 : 9740-9744 (Pubitemid 38869306)
9. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies : molecular, clinical and therapeutic implications. Leukemia 2008 ; 22 : 1095-1105
10. Ma L, Weinberg RA. Micromanagers of malignancy : role of microRNAs in regulating metastasis. Trends Genet 2008 ; 24 : 448-456
11. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Meth 2004 ; 1 : 155-161
12. Rebouissou S, Couchy G, Libbrecht L, et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008 ; 49 : 61-71.
13. Bluteau O, Jeannot E, Bioulac-Sage P, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002 ; 32 : 312-315
14. Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms : beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002 ; 36 : 927-935
15. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma : new classification and relationship with HCC. Hepatology 2006 ; 43 : 515-524
16. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2008 ; 457 : 200-204
17. Zucman-Rossi J, Amessou M, Bioulac-Sage P, Rebouissou S. Gp130 activating mutations in inflammatory adenomas. Med Sci (Paris) 2008 ; 24 : 1113-1114
18. Boyault S, Rickman DS, de Reynies A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007 ; 45 : 42-52. (Pubitemid 46144363)
19. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology (Baltimore, Md 2008 ; 47 : 1955-1963
20. Jiang J, Gusev Y, Aderca I, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008 ; 14 : 419-427
21. Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008 ; 47 : 1223-1232
22. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 ; 25 : 2537-2545
23. Kutay H, Bai S, Datta J, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006 ; 99 : 671-678 (Pubitemid 44521987)
24. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007 ; 133 : 647-658 (Pubitemid 47187346)
25. Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007 ; 67 : 6092-6099 (Pubitemid 47037488)
26. Huang YS, Dai Y, Yu XF, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008 ; 23 : 87-94. (Pubitemid 350265207)
27. Wang Y, Lee AT, Ma JZ, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008 ; 283 : 13205-13215
28. Connolly E, Melegari M, Landgraf P, et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008 ; 173 : 856-864
29. Varnholt H. The role of microRNAs in primary liver cancer. Ann Hepatol 2008 ; 7 : 104-113
30. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008 ; 48 : 648-656
31. Jopling CL, Norman KL, Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harbor symposia on quantitative biology 2006 ; 71 : 369-376
32. Franhel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008 ; 283 : 1026-1033
33. Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007 ; 282 : 23716-23724 (Pubitemid 47311902)
34. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009 ; 136 : 683-693
35. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008 ; 47 : 897-907.
36. Bousquet M, Dastugue N, Brousset P. MicroARN et translocations chromosomiques dans les hémopathies malignes. Med Sci 2009 (sous presse).
37. Dunoyer P. La bataille du silence : mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 2009 ; 25 : 505-511